Home › Companies › BIOGEN INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and BIOGEN INC.’s Form 8-K, filed June 25, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 20, 2024: 14 items on BIOGEN INC.’s Form 8-K, filed June 25, 2024: 5 approved · 9 passed (calculated).
Significant dissent: 2 directors (26.4%, 22.5% against).
Notable dissent: 5 directors (19.7%, 19.2%, 16.6%, 15.7%, 15.3% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore BIOGEN INC. in the interactive database Compare manager voting policies
These tallies are BIOGEN INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 25, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Caroline D. Dorsa | 87,883,981 | 31,591,984 | 84,665 | -- | 9,672,399 | 74% | Passed (calculated) | — |
| Elect Director: Maria C. Freire | 100,691,870 | 18,771,139 | 97,621 | -- | 9,672,399 | 84% | Passed (calculated) | — |
| Elect Director: William A. Hawkins | 95,931,549 | 23,539,595 | 89,486 | -- | 9,672,399 | 80% | Passed (calculated) | — |
| Elect Director: Susan K. Langer | 92,603,948 | 26,870,919 | 85,763 | -- | 9,672,399 | 78% | Passed (calculated) | — |
| Elect Director: Jesus B. Mantas | 99,615,562 | 19,856,501 | 88,567 | -- | 9,672,399 | 83% | Passed (calculated) | — |
| Elect Director: Monish Patolawala | 119,078,211 | 388,227 | 94,192 | -- | 9,672,399 | 99.7% | Passed (calculated) | — |
| Elect Director: Eric K. Rowinsky | 96,514,372 | 22,954,348 | 91,910 | -- | 9,672,399 | 81% | Passed (calculated) | — |
| Elect Director: Stephen A. Sherwin | 101,152,837 | 18,318,068 | 89,725 | -- | 9,672,399 | 85% | Passed (calculated) | — |
| Elect Director: Christopher A. Viehbacher | 118,593,483 | 886,743 | 80,404 | -- | 9,672,399 | 99.3% | Passed (calculated) | — |
| 2. The selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, with the votes cast | 123,728,418 | 5,348,316 | 156,295 | -- | -- | 96% | Approved | — |
| 3. Advisory vote on executive compensation, with the votes cast | 114,367,799 | 5,054,473 | 138,358 | -- | 9,672,399 | 96% | Approved | — |
| 4. The amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision, with the votes cast | 103,146,578 | 16,274,796 | 139,256 | -- | 9,672,399 | 86% | Approved | — |
| 5. Stockholders approved the adoption of the Biogen Inc. | 112,726,169 | 6,693,956 | 140,505 | -- | 9,672,399 | 94% | Approved | — |
| 6. Stockholders approved the adoption of the Biogen Inc. | 119,064,435 | 413,475 | 82,720 | -- | 9,672,399 | 99.7% | Approved | — |
Source: BIOGEN INC., Form 8-K, filed with the SEC on June 25, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
875 asset managers disclosed a vote on at least one BIOGEN INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BIOGEN INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 7 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Caroline D. Dorsa
BIOGEN INC.’s own tally for this item (“Elect Director: Caroline D. Dorsa”): 87,883,981 for, 31,591,984 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 74% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 148 asset managers below reported 43,775,381 for, 22,844,611 against, 15,868 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 15,931,761 | 17,497,468 | 0 | 0 | Mixed |
| BlackRock | 5,511,108 | 2,243 | 0 | 0 | For |
| T. Rowe Price | 3,323,303 | 897,693 | 0 | 0 | Mixed |
| Fidelity | 3,588,836 | 288,418 | 0 | 0 | Mixed |
| PRIMECAP Odyssey Funds | 0 | 2,212,789 | 0 | 0 | Against |
| State Street | 1,762,672 | 284 | 0 | 0 | For |
| VanEck ETF Trust | 1,647,240 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 1,241,920 | 0 | 0 | Against |
| Invesco | 1,126,977 | 0 | 0 | 0 | For |
| Jackson National | 1,084,731 | 28,092 | 0 | 0 | For |
| Dimensional | 887,791 | 0 | 0 | 0 | For |
| Charles Schwab | 855,363 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 636,485 | 0 | 0 | 0 | For |
| American Century | 594,866 | 0 | 0 | 0 | For |
| Legg Mason | 569,667 | 0 | 0 | 0 | For |
| MFS | 437,359 | 0 | 0 | 0 | For |
| First Trust | 411,978 | 0 | 0 | 0 | For |
| Parnassus | 360,742 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 351,630 | 0 | 0 | 0 | For |
| TIAA | 337,828 | 0 | 0 | 0 | For |
| Voya | 297,718 | 0 | 0 | 0 | For |
| Aberdeen | 287,651 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 266,161 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 227,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Prior year: 98.3% for (June 26, 2023 meeting) ▲ 1.0 pts
Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher
BIOGEN INC.’s own tally for this item (“Elect Director: Christopher A. Viehbacher”): 118,593,483 for, 886,743 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 148 asset managers below reported 66,618,866 for, 1,125 against, 15,867 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,429,229 | 0 | 0 | 0 | For |
| BlackRock | 5,512,579 | 772 | 0 | 0 | For |
| T. Rowe Price | 4,220,996 | 0 | 0 | 0 | For |
| Fidelity | 3,877,254 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,212,789 | 0 | 0 | 0 | For |
| State Street | 1,762,867 | 89 | 0 | 0 | For |
| VanEck ETF Trust | 1,647,240 | 0 | 0 | 0 | For |
| JPMorgan | 1,241,920 | 0 | 0 | 0 | For |
| Invesco | 1,126,977 | 0 | 0 | 0 | For |
| Jackson National | 1,112,823 | 0 | 0 | 0 | For |
| Dimensional | 887,791 | 0 | 0 | 0 | For |
| Charles Schwab | 855,363 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 636,485 | 0 | 0 | 0 | For |
| American Century | 594,866 | 0 | 0 | 0 | For |
| Legg Mason | 569,667 | 0 | 0 | 0 | For |
| MFS | 437,359 | 0 | 0 | 0 | For |
| First Trust | 411,978 | 0 | 0 | 0 | For |
| Parnassus | 360,742 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 351,630 | 0 | 0 | 0 | For |
| TIAA | 337,828 | 0 | 0 | 0 | For |
| Voya | 297,718 | 0 | 0 | 0 | For |
| Aberdeen | 287,651 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 266,161 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 227,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
Prior year: 57.2% for (June 26, 2023 meeting) ▲ 23.6 pts
Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky
BIOGEN INC.’s own tally for this item (“Elect Director: Eric K. Rowinsky”): 96,514,372 for, 22,954,348 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 148 asset managers below reported 50,106,623 for, 16,513,368 against, 15,868 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,490,214 | 12,939,015 | 0 | 0 | Mixed |
| BlackRock | 5,511,108 | 2,243 | 0 | 0 | For |
| T. Rowe Price | 3,323,303 | 897,693 | 0 | 0 | Mixed |
| Fidelity | 3,789,997 | 87,257 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 0 | 2,212,789 | 0 | 0 | Against |
| State Street | 1,762,672 | 284 | 0 | 0 | For |
| VanEck ETF Trust | 1,647,240 | 0 | 0 | 0 | For |
| JPMorgan | 1,241,920 | 0 | 0 | 0 | For |
| Invesco | 1,126,977 | 0 | 0 | 0 | For |
| Jackson National | 1,112,410 | 413 | 0 | 0 | For |
| Dimensional | 887,791 | 0 | 0 | 0 | For |
| Charles Schwab | 855,363 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 636,485 | 0 | 0 | 0 | For |
| American Century | 594,866 | 0 | 0 | 0 | For |
| Legg Mason | 569,667 | 0 | 0 | 0 | For |
| MFS | 437,359 | 0 | 0 | 0 | For |
| First Trust | 411,978 | 0 | 0 | 0 | For |
| Parnassus | 360,742 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 351,630 | 0 | 0 | 0 | For |
| TIAA | 337,828 | 0 | 0 | 0 | For |
| Voya | 297,718 | 0 | 0 | 0 | For |
| Aberdeen | 287,651 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 266,161 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 227,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Prior year: 77.4% for (June 26, 2023 meeting) ▲ 6.0 pts
Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas
BIOGEN INC.’s own tally for this item (“Elect Director: Jesus B. Mantas”): 99,615,562 for, 19,856,501 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 148 asset managers below reported 50,266,157 for, 16,353,834 against, 15,868 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,490,214 | 12,939,015 | 0 | 0 | Mixed |
| BlackRock | 5,512,579 | 772 | 0 | 0 | For |
| T. Rowe Price | 3,323,303 | 897,693 | 0 | 0 | Mixed |
| Fidelity | 3,789,997 | 87,257 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 0 | 2,212,789 | 0 | 0 | Against |
| State Street | 1,762,887 | 69 | 0 | 0 | For |
| VanEck ETF Trust | 1,647,240 | 0 | 0 | 0 | For |
| JPMorgan | 1,241,920 | 0 | 0 | 0 | For |
| Invesco | 1,126,977 | 0 | 0 | 0 | For |
| Jackson National | 1,112,410 | 413 | 0 | 0 | For |
| Dimensional | 887,791 | 0 | 0 | 0 | For |
| Charles Schwab | 855,363 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 636,485 | 0 | 0 | 0 | For |
| American Century | 594,866 | 0 | 0 | 0 | For |
| Legg Mason | 569,667 | 0 | 0 | 0 | For |
| MFS | 437,359 | 0 | 0 | 0 | For |
| First Trust | 411,978 | 0 | 0 | 0 | For |
| Parnassus | 360,742 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 351,630 | 0 | 0 | 0 | For |
| TIAA | 337,828 | 0 | 0 | 0 | For |
| Voya | 297,718 | 0 | 0 | 0 | For |
| Aberdeen | 287,651 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 266,161 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 227,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Prior year: 63.7% for (June 26, 2023 meeting) ▲ 20.6 pts
Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire
BIOGEN INC.’s own tally for this item (“Elect Director: Maria C. Freire”): 100,691,870 for, 18,771,139 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 148 asset managers below reported 51,466,937 for, 15,153,054 against, 15,869 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,490,214 | 12,939,015 | 0 | 0 | Mixed |
| BlackRock | 5,512,579 | 772 | 0 | 0 | For |
| T. Rowe Price | 4,220,996 | 0 | 0 | 0 | For |
| Fidelity | 3,877,254 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 0 | 2,212,789 | 0 | 0 | Against |
| State Street | 1,762,887 | 69 | 0 | 0 | For |
| VanEck ETF Trust | 1,647,240 | 0 | 0 | 0 | For |
| JPMorgan | 1,241,920 | 0 | 0 | 0 | For |
| Invesco | 1,126,977 | 0 | 0 | 0 | For |
| Jackson National | 1,112,823 | 0 | 0 | 0 | For |
| Dimensional | 887,791 | 0 | 0 | 0 | For |
| Charles Schwab | 855,363 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 636,485 | 0 | 0 | 0 | For |
| American Century | 594,866 | 0 | 0 | 0 | For |
| Legg Mason | 569,667 | 0 | 0 | 0 | For |
| MFS | 437,359 | 0 | 0 | 0 | For |
| First Trust | 411,978 | 0 | 0 | 0 | For |
| Parnassus | 360,742 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 351,630 | 0 | 0 | 0 | For |
| TIAA | 337,828 | 0 | 0 | 0 | For |
| Voya | 297,718 | 0 | 0 | 0 | For |
| Aberdeen | 287,651 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 266,161 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 227,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala
BIOGEN INC.’s own tally for this item (“Elect Director: Monish Patolawala”): 119,078,211 for, 388,227 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 148 asset managers below reported 66,619,758 for, 232 against, 15,868 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,429,229 | 0 | 0 | 0 | For |
| BlackRock | 5,513,351 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,220,996 | 0 | 0 | 0 | For |
| Fidelity | 3,877,254 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,212,789 | 0 | 0 | 0 | For |
| State Street | 1,762,956 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 1,647,240 | 0 | 0 | 0 | For |
| JPMorgan | 1,241,920 | 0 | 0 | 0 | For |
| Invesco | 1,126,977 | 0 | 0 | 0 | For |
| Jackson National | 1,112,823 | 0 | 0 | 0 | For |
| Dimensional | 887,791 | 0 | 0 | 0 | For |
| Charles Schwab | 855,363 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 636,485 | 0 | 0 | 0 | For |
| American Century | 594,866 | 0 | 0 | 0 | For |
| Legg Mason | 569,667 | 0 | 0 | 0 | For |
| MFS | 437,359 | 0 | 0 | 0 | For |
| First Trust | 411,978 | 0 | 0 | 0 | For |
| Parnassus | 360,742 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 351,630 | 0 | 0 | 0 | For |
| TIAA | 337,828 | 0 | 0 | 0 | For |
| Voya | 297,718 | 0 | 0 | 0 | For |
| Aberdeen | 287,651 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 266,161 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 227,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Prior year: 78.2% for (June 26, 2023 meeting) ▲ 6.4 pts
Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin
BIOGEN INC.’s own tally for this item (“Elect Director: Stephen A. Sherwin”): 101,152,837 for, 18,318,068 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 148 asset managers below reported 51,349,436 for, 15,270,555 against, 15,868 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,490,214 | 12,939,015 | 0 | 0 | Mixed |
| BlackRock | 5,512,579 | 772 | 0 | 0 | For |
| T. Rowe Price | 4,220,996 | 0 | 0 | 0 | For |
| Fidelity | 3,877,254 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 0 | 2,212,789 | 0 | 0 | Against |
| State Street | 1,762,801 | 155 | 0 | 0 | For |
| VanEck ETF Trust | 1,647,240 | 0 | 0 | 0 | For |
| JPMorgan | 1,241,920 | 0 | 0 | 0 | For |
| Invesco | 1,126,977 | 0 | 0 | 0 | For |
| Jackson National | 1,112,823 | 0 | 0 | 0 | For |
| Dimensional | 887,791 | 0 | 0 | 0 | For |
| Charles Schwab | 855,363 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 636,485 | 0 | 0 | 0 | For |
| American Century | 594,866 | 0 | 0 | 0 | For |
| Legg Mason | 569,667 | 0 | 0 | 0 | For |
| MFS | 437,359 | 0 | 0 | 0 | For |
| First Trust | 411,978 | 0 | 0 | 0 | For |
| Parnassus | 360,742 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 351,630 | 0 | 0 | 0 | For |
| TIAA | 337,828 | 0 | 0 | 0 | For |
| Voya | 297,718 | 0 | 0 | 0 | For |
| Aberdeen | 287,651 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 266,161 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 227,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer
BIOGEN INC.’s own tally for this item (“Elect Director: Susan K. Langer”): 92,603,948 for, 26,870,919 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 148 asset managers below reported 44,057,451 for, 22,562,540 against, 15,868 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 15,931,761 | 17,497,468 | 0 | 0 | Mixed |
| BlackRock | 5,512,579 | 772 | 0 | 0 | For |
| T. Rowe Price | 3,323,303 | 897,693 | 0 | 0 | Mixed |
| Fidelity | 3,588,836 | 288,418 | 0 | 0 | Mixed |
| PRIMECAP Odyssey Funds | 0 | 2,212,789 | 0 | 0 | Against |
| State Street | 1,762,887 | 69 | 0 | 0 | For |
| VanEck ETF Trust | 1,647,240 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 1,241,920 | 0 | 0 | Against |
| Invesco | 1,126,977 | 0 | 0 | 0 | For |
| Jackson National | 1,084,731 | 28,092 | 0 | 0 | For |
| Dimensional | 887,791 | 0 | 0 | 0 | For |
| Charles Schwab | 855,363 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 636,485 | 0 | 0 | 0 | For |
| American Century | 594,866 | 0 | 0 | 0 | For |
| Legg Mason | 569,667 | 0 | 0 | 0 | For |
| MFS | 437,359 | 0 | 0 | 0 | For |
| First Trust | 411,978 | 0 | 0 | 0 | For |
| Parnassus | 360,742 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 351,630 | 0 | 0 | 0 | For |
| TIAA | 337,828 | 0 | 0 | 0 | For |
| Voya | 297,718 | 0 | 0 | 0 | For |
| Aberdeen | 287,651 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 266,161 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 227,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Prior year: 61.5% for (June 26, 2023 meeting) ▲ 18.8 pts
Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins
BIOGEN INC.’s own tally for this item (“Elect Director: William A. Hawkins”): 95,931,549 for, 23,539,595 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 148 asset managers below reported 46,803,932 for, 19,816,059 against, 15,868 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 15,931,761 | 17,497,468 | 0 | 0 | Mixed |
| BlackRock | 5,511,108 | 2,243 | 0 | 0 | For |
| T. Rowe Price | 4,220,996 | 0 | 0 | 0 | For |
| Fidelity | 3,864,951 | 12,303 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 0 | 2,212,789 | 0 | 0 | Against |
| State Street | 1,762,759 | 197 | 0 | 0 | For |
| VanEck ETF Trust | 1,647,240 | 0 | 0 | 0 | For |
| JPMorgan | 1,241,920 | 0 | 0 | 0 | For |
| Invesco | 1,126,977 | 0 | 0 | 0 | For |
| Jackson National | 1,112,823 | 0 | 0 | 0 | For |
| Dimensional | 887,791 | 0 | 0 | 0 | For |
| Charles Schwab | 855,363 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 636,485 | 0 | 0 | 0 | For |
| American Century | 594,866 | 0 | 0 | 0 | For |
| Legg Mason | 569,667 | 0 | 0 | 0 | For |
| MFS | 437,359 | 0 | 0 | 0 | For |
| First Trust | 411,978 | 0 | 0 | 0 | For |
| Parnassus | 360,742 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 351,630 | 0 | 0 | 0 | For |
| TIAA | 337,828 | 0 | 0 | 0 | For |
| Voya | 297,718 | 0 | 0 | 0 | For |
| Aberdeen | 287,651 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 266,161 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 227,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
86% Approved · of votes cast
Description as filed by funds: To approve an amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision.
BIOGEN INC.’s own tally for this item (“4. The amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision, with the votes cast”): 103,146,578 for, 16,274,796 against — passed, per its Form 8-K filed June 25, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders approved the amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision, with the votes cast as follows:”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of BIOGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Approve Article Amendments” (2 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
The 148 asset managers below reported 61,543,295 for, 5,076,693 against, 15,871 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,429,229 | 0 | 0 | 0 | For |
| BlackRock | 5,509,250 | 4,101 | 0 | 0 | For |
| T. Rowe Price | 4,220,996 | 0 | 0 | 0 | For |
| Fidelity | 3,688,396 | 188,858 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,212,789 | 0 | 0 | 0 | For |
| State Street | 1,762,869 | 87 | 0 | 0 | For |
| VanEck ETF Trust | 0 | 1,647,240 | 0 | 0 | Against |
| JPMorgan | 0 | 1,241,920 | 0 | 0 | Against |
| Invesco | 1,126,977 | 0 | 0 | 0 | For |
| Jackson National | 1,085,144 | 27,679 | 0 | 0 | For |
| Dimensional | 887,791 | 0 | 0 | 0 | For |
| Charles Schwab | 855,363 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 636,485 | 0 | 0 | 0 | For |
| American Century | 594,866 | 0 | 0 | 0 | For |
| Legg Mason | 1,562 | 568,105 | 0 | 0 | Against |
| MFS | 437,359 | 0 | 0 | 0 | For |
| First Trust | 411,978 | 0 | 0 | 0 | For |
| Parnassus | 0 | 360,742 | 0 | 0 | Against |
| Brown Advisory Funds | 0 | 351,630 | 0 | 0 | Against |
| TIAA | 337,828 | 0 | 0 | 0 | For |
| Voya | 297,718 | 0 | 0 | 0 | For |
| Aberdeen | 287,651 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 266,161 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 227,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99% of fund votes cast · no official result
The 149 asset managers below reported 65,567,919 for, 781,136 against, 9 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,429,229 | 0 | 0 | 0 | For |
| BlackRock | 5,513,351 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,220,996 | 0 | 0 | 0 | For |
| Fidelity | 3,877,254 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,212,789 | 0 | 0 | 0 | For |
| State Street | 1,762,869 | 87 | 0 | 0 | For |
| VanEck ETF Trust | 1,647,240 | 0 | 0 | 0 | For |
| JPMorgan | 1,241,920 | 0 | 0 | 0 | For |
| Invesco | 1,126,977 | 0 | 0 | 0 | For |
| Jackson National | 1,112,823 | 0 | 0 | 0 | For |
| Dimensional | 887,791 | 0 | 0 | 0 | For |
| Charles Schwab | 855,363 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 636,485 | 0 | 0 | 0 | For |
| American Century | 0 | 594,866 | 0 | 0 | Against |
| Legg Mason | 569,667 | 0 | 0 | 0 | For |
| MFS | 437,359 | 0 | 0 | 0 | For |
| First Trust | 411,978 | 0 | 0 | 0 | For |
| Parnassus | 360,742 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 351,630 | 0 | 0 | 0 | For |
| TIAA | 337,828 | 0 | 0 | 0 | For |
| Voya | 297,718 | 0 | 0 | 0 | For |
| Aberdeen | 287,651 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 227,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,158 | 0 | 0 | 0 | For |
| ProShares | 188,102 | 0 | 0 | 0 | For |
Showing the 25 largest of 149 asset managers. All 149 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
The 147 asset managers below reported 66,333,672 for, 15,212 against, 5 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,429,229 | 0 | 0 | 0 | For |
| BlackRock | 5,513,351 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,220,996 | 0 | 0 | 0 | For |
| Fidelity | 3,877,254 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,212,789 | 0 | 0 | 0 | For |
| State Street | 1,762,956 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 1,647,240 | 0 | 0 | 0 | For |
| JPMorgan | 1,241,920 | 0 | 0 | 0 | For |
| Invesco | 1,126,977 | 0 | 0 | 0 | For |
| Jackson National | 1,112,823 | 0 | 0 | 0 | For |
| Dimensional | 887,791 | 0 | 0 | 0 | For |
| Charles Schwab | 855,363 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 636,485 | 0 | 0 | 0 | For |
| American Century | 594,866 | 0 | 0 | 0 | For |
| Legg Mason | 569,667 | 0 | 0 | 0 | For |
| MFS | 437,359 | 0 | 0 | 0 | For |
| First Trust | 411,978 | 0 | 0 | 0 | For |
| Parnassus | 360,742 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 351,630 | 0 | 0 | 0 | For |
| TIAA | 337,828 | 0 | 0 | 0 | For |
| Voya | 297,718 | 0 | 0 | 0 | For |
| Aberdeen | 287,651 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 227,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,158 | 0 | 0 | 0 | For |
| ProShares | 188,102 | 0 | 0 | 0 | For |
Showing the 25 largest of 147 asset managers. All 147 are in the interactive database (link above).
Combines 10 wordings of this item as funds reported it.
96% Approved · of votes cast
Prior year: 69.5% for (June 26, 2023 meeting) ▲ 26.3 pts
Description as filed by funds: Say on Pay - To hold an advisory vote on executive compensation.
BIOGEN INC.’s own tally for this item (“3. The advisory vote on executive compensation, with the votes cast”): 114,367,799 for, 5,054,473 against — passed, per its Form 8-K filed June 25, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of BIOGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (33 managers, 4,104,101 for, 200,983 against, 884 abstained, 2 1 year); “14A Executive Compensation” (23 managers, 97,419 for); “Compensation” (2 managers, 450 for).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,429,229 | 0 | 0 | 0 | For |
| BlackRock | 5,513,351 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,220,996 | 0 | 0 | 0 | For |
| Fidelity | 3,877,254 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,212,789 | 0 | 0 | 0 | For |
| State Street | 1,762,956 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 1,647,240 | 0 | 0 | 0 | For |
| JPMorgan | 1,241,920 | 0 | 0 | 0 | For |
| Invesco | 1,126,977 | 0 | 0 | 0 | For |
| Jackson National | 1,112,823 | 0 | 0 | 0 | For |
| Dimensional | 887,791 | 0 | 0 | 0 | For |
| Charles Schwab | 855,363 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 636,485 | 0 | 0 | 0 | For |
| American Century | 594,866 | 0 | 0 | 0 | For |
| Legg Mason | 569,667 | 0 | 0 | 0 | For |
| MFS | 437,359 | 0 | 0 | 0 | For |
| First Trust | 411,978 | 0 | 0 | 0 | For |
| Parnassus | 360,742 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 351,630 | 0 | 0 | 0 | For |
| TIAA | 337,828 | 0 | 0 | 0 | For |
| Voya | 297,718 | 0 | 0 | 0 | For |
| Aberdeen | 287,651 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 227,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,158 | 0 | 0 | 0 | For |
| ProShares | 188,102 | 0 | 0 | 0 | For |
Fund voting reports, all 141 managers: 66,295,264 for, 39,686 against, 14,987 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 15,773,607 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,101,374 | 0 | 0 | 0 | For |
| BlackRock | 6,032,741 | 0 | 0 | 0 | For |
| Wellington | 5,019,456 | 0 | 0 | 0 | For |
| State Street | 4,165,343 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 3,429,316 | 0 | 0 | 0 | For |
| VAN ECK ASSOCIATES CORP | 1,650,355 | 0 | 0 | 0 | For |
| Beutel, Goodman & Co Ltd. | 1,541,150 | 0 | 0 | 0 | For |
| Clearbridge Investments, LLC | 1,539,243 | 0 | 0 | 0 | For |
| Northern Trust | 1,360,542 | 2,988 | 0 | 0 | For |
| Invesco | 1,207,937 | 0 | 0 | 0 | For |
| Fidelity | 1,132,751 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 1,027,596 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 0 | 940,950 | 0 | 0 | Against |
| Amundi | 0 | 892,319 | 0 | 0 | Against |
| Charles Schwab | 884,568 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 872,953 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 732,620 | 0 | 0 | 0 | For |
| American Century | 677,986 | 0 | 0 | 0 | For |
| Vanguard | 632,792 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 629,024 | 0 | 0 | 0 | For |
| UBS | 603,858 | 0 | 0 | 0 | For |
| Goldman Sachs | 466,112 | 0 | 0 | 0 | For |
| Aberdeen | 456,417 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 432,102 | 0 | 0 | 0 | For |
Institutional-manager reports, all 703 managers: 70,111,035 for, 3,595,455 against, 49,226 abstained, 1,782 not voted, 35 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
96% Approved · of votes cast
Prior year: 96.6% for (June 26, 2023 meeting) ▼ 0.8 pts
Description as filed by funds: To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2024.
BIOGEN INC.’s own tally for this item (“2. The selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, with the votes cast”): 123,728,418 for, 5,348,316 against — passed, per its Form 8-K filed June 25, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, with the votes cast as follows:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of BIOGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (2 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
The 148 asset managers below reported 66,490,374 for, 129,617 against, 15,868 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,429,229 | 0 | 0 | 0 | For |
| BlackRock | 5,513,351 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,220,996 | 0 | 0 | 0 | For |
| Fidelity | 3,877,254 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,212,789 | 0 | 0 | 0 | For |
| State Street | 1,762,869 | 87 | 0 | 0 | For |
| VanEck ETF Trust | 1,647,240 | 0 | 0 | 0 | For |
| JPMorgan | 1,241,920 | 0 | 0 | 0 | For |
| Invesco | 1,126,977 | 0 | 0 | 0 | For |
| Jackson National | 1,112,823 | 0 | 0 | 0 | For |
| Dimensional | 887,791 | 0 | 0 | 0 | For |
| Charles Schwab | 855,363 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 636,485 | 0 | 0 | 0 | For |
| American Century | 594,866 | 0 | 0 | 0 | For |
| Legg Mason | 569,667 | 0 | 0 | 0 | For |
| MFS | 437,359 | 0 | 0 | 0 | For |
| First Trust | 411,978 | 0 | 0 | 0 | For |
| Parnassus | 360,742 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 351,630 | 0 | 0 | 0 | For |
| TIAA | 337,828 | 0 | 0 | 0 | For |
| Voya | 297,718 | 0 | 0 | 0 | For |
| Aberdeen | 287,651 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 266,161 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 227,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 1 item from the meeting of June 17, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 144,900,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 23.07% |
| 2 | BlackRock | 3.80% |
| 3 | T. Rowe Price | 2.91% |
| 4 | Fidelity | 2.68% |
| 5 | PRIMECAP Odyssey Funds | 1.53% |
| 6 | State Street | 1.22% |
| 7 | VanEck ETF Trust | 1.14% |
| 8 | JPMorgan | 0.86% |
| 9 | Invesco | 0.78% |
| 10 | Jackson National | 0.77% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | PRIMECAP MANAGEMENT CO/CA/ | 10.89% |
| 2 | T. Rowe Price | 4.90% |
| 3 | BlackRock | 4.16% |
| 4 | Wellington | 3.46% |
| 5 | State Street | 2.87% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.37% |
| 7 | VAN ECK ASSOCIATES CORP | 1.14% |
| 8 | Beutel, Goodman & Co Ltd. | 1.06% |
| 9 | Clearbridge Investments, LLC | 1.06% |
| 10 | Northern Trust | 0.94% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Vanguard Group | 17,289,235 | 11.93% | Form 13F, quarter ended March 31, 2024 |
| BlackRock | 14,763,952 | 10.19% | Form 13F, quarter ended March 31, 2024 |
| Biogen MA Inc. | 7,155,243 | 4.94% | Schedule 13G, filed November 7, 2024 |
| State Street | 6,747,008 | 4.66% | Form 13F, quarter ended March 31, 2024 |
| Wellington Management | 5,120,142 | 3.53% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 3,409,674 | 2.35% | Form 13F, quarter ended March 31, 2024 |
| Morgan Stanley | 2,251,535 | 1.55% | Form 13F, quarter ended March 31, 2024 |
| Invesco | 1,668,017 | 1.15% | Form 13F, quarter ended March 31, 2024 |
| T. Rowe Price | 1,589,629 | 1.10% | Form 13F, quarter ended March 31, 2024 |
| Northern Trust | 1,388,386 | 0.96% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 144,900,000 shares outstanding, as reported by BIOGEN INC. on its Form 10-K dated December 31, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At BIOGEN INC.'s shareholder meeting held June 20, 2024, in the 2023-2024 proxy season, 875 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 12,171 separate fund positions. Their filings are grouped here into 14 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Say on Pay - To hold an advisory vote on executive compensation. — BIOGEN INC.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: BIOGEN INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 25, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BIOGEN INC.’s 10-K dated December 31, 2023. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
BIOGEN INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “BIOGEN (BIIB) 2024 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/biogen-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.